This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Google Scholar Articles by Skinningsrud, B. Articles by Undlien, D. E. PubMed PubMed Citation Articles by Skinningsrud, B. Articles by Undlien, D. E. Related Collections Adrenal and Hypertension Neuroendocrinology and Pituitary Pediatric Endocrinology

X-Linked Congenital Adrenal Hypoplasia with Hypogonadotropic Hypogonadism Caused by an Inversion Disrupting a Conserved Noncoding Element Upstream of the NR0B1 (DAX1) Gene

Department of Medical Genetics (B.S., G.D.G., K.G., E.O., D.E.U.), Oslo University Hospital, Ullevål, N-0407 Oslo, Norway; Institute of Medical Genetics (B.S., E.F., K.G., D.E.U.), University of Oslo, N-0315 Oslo, Norway; Section of Endocrinology (E.S.H.), Institute of Medicine, University of Bergen, N-5021 Bergen, Norway; Department of Medicine (E.S.H.), Haukeland University Hospital, N-5021 Bergen, Norway; Department of Pathology (A.E.), Oslo University Hospital, Ullevål, N-0407 Oslo, Norway; and Institute of Forensic Medicine (T.E.), University of Oslo, N-0027 Oslo, Norway

Address all correspondence and requests for reprints to: Beate Skinningsrud, Department of Medical Genetics, Oslo University Hospital, Ullevål, Kirkeveien 166, N-0407 Oslo, Norway. E-mail: beate.skinningsrud{at}medisin.uio.no.

Context: X-linked congenital adrenal hypoplasia with hypogonadotropic hypogonadism (AHCH) is known to be caused by coding mutations in the nuclear receptor subfamily 0, group B, member 1 (NR0B1) gene, encoding the transcriptional repressor dosage-sensitive sex-reversal adrenal hypoplasia critical region on the X chromosome protein 1 (DAX1).

Objective/Patients: Four males in a family were affected by AHCH. Our aim was to locate the genetic cause of their disease, knowing that they had no mutation in the obvious candidate gene, NR0B1.

Design: Linkage analysis of the X chromosome and mutational screening of conserved noncoding regions upstream of NR0B1 were performed. To functionally characterize the genetic defect, studies of transcription and expression of DAX1 and steroidogenic factor 1 (SF-1) were done.

Results: A 60 Mb inversion on the X chromosome with one of the inversion breakpoints located in a conserved noncoding region 4 kb upstream of NR0B1 was detected. The inversion causes relocation of a putative SF-1 binding site implicated in murine gonadal development. A reporter construct lacking this enhancer element upstream of NR0B1 was unresponsive to SF-1 transcriptional activation. Immunohistochemistry suggested that the inversion leads to SF-1 silencing in the patients’ testes both in childhood and in adult life.

Conclusion: We report a noncoding mutation causing AHCH, an inversion resulting in a phenotype similar to what is caused by intragenic NR0B1 null mutations. The inversion seems to disrupt and/or relocate regulatory sites crucial in DAX1 expression.